CAPTRUST Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,953
Closed -$399K 2357
2024
Q4
$399K Sell
16,953
-2,012
-11% -$49.5K ﹤0.01% 1735
2024
Q3
$485K Buy
+18,965
New +$483K ﹤0.01% 1587
2024
Q2
Sell
-13,565
Closed -$390K 2201
2024
Q1
$390K Sell
13,565
-4,040
-23% -$121K ﹤0.01% 1622
2023
Q4
$578K Sell
17,605
-476
-3% -$12.9K ﹤0.01% 1646
2023
Q3
$504K Sell
18,081
-5,145
-22% -$168K ﹤0.01% 1644
2023
Q2
$792K Buy
23,226
+10,612
+84% +$334K ﹤0.01% 1349
2023
Q1
$379K Sell
12,614
-7,747
-38% -$240K ﹤0.01% 1568
2022
Q4
$575K Buy
20,361
+4,570
+29% +$145K ﹤0.01% 1266
2022
Q3
$519K Sell
15,791
-18,297
-54% -$672K ﹤0.01% 1225
2022
Q2
$1.07M Buy
34,088
+25,109
+280% +$878K 0.01% 800
2022
Q1
$412K Sell
8,979
-7,928
-47% -$378K ﹤0.01% 1244
2021
Q4
$1.03M Sell
16,907
-6,296
-27% -$435K 0.01% 801
2021
Q3
$1.73M Buy
23,203
+5,937
+34% +$498K 0.01% 557
2021
Q2
$1.6M Buy
17,266
+821
+5% +$69.8K 0.01% 562
2021
Q1
$1.46M Buy
16,445
+10,216
+164% +$1.01M 0.02% 551
2020
Q4
$581K Buy
6,229
+5,453
+703% +$434K 0.01% 780
2020
Q3
$50K Buy
776
+334
+76% +$19.6K ﹤0.01% 1624
2020
Q2
$24K Buy
+442
New +$19K ﹤0.01% 1866

Other funds holding ARKG

CAPTRUST Financial Advisors's ARKG Position: Q1 2025 in Review

CAPTRUST Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 16,953 shares — an estimated $399K sold.

CAPTRUST Financial Advisors first reported a position in ARKG in Q2 2020 and held it in 18 quarters. The position peaked at $1.73M in Q3 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • CAPTRUST Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 16,953 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $399K.
  • CAPTRUST Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 18 quarters.
  • CAPTRUST Financial Advisors's ARK Genomic Revolution ETF position peaked at $1.73M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.